SCHEMBL17405644

SCHEMBL17405644

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5c6c7ccccc7oc6c6c7ccccc7oc6c54)cc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HSD17B10 Q99714 3/20 0.34
POLB P06746 2/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 4/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
HPGD P15428 3/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALPI P09923 1/20 0.32
PKM P14618 1/20 0.32
CASP3 P42574 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17405627 1.00 MEN1 (0.34) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17405513 0.97 MEN1 (0.34) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17405520 0.97 MEN1 (0.34) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17406165 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17406172 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17405918 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17405909 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17406083 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17405360 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB
SCHEMBL17406087 0.95 ALDH1A1 (0.35) MEN1KMT2AALDH1A1HSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE ODC1, NOTUM, OR10J3 MEN1 1833/4885KMT2A 1292/4885ALDH1A1 1348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.